Q3 EPS Estimate for Great-West Lifeco Boosted by Analyst

Great-West Lifeco Inc. (TSE:GWO - Free Report) - National Bank Financial increased their Q3 2024 earnings estimates for shares of Great-West Lifeco in a note issued to investors on Thursday, October 24th. National Bank Financial analyst G. Dechaine now anticipates that the company will post earnings per share of $1.10 for the quarter, up from their previous estimate of $1.08. The consensus estimate for Great-West Lifeco's current full-year earnings is $4.45 per share. National Bank Financial also issued estimates for Great-West Lifeco's Q4 2024 earnings at $1.09 EPS, FY2024 earnings at $4.34 EPS and FY2025 earnings at $4.63 EPS.

Great-West Lifeco (TSE:GWO - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported C$1.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of C$1.05 by C$0.06. The business had revenue of C$8.61 billion during the quarter, compared to the consensus estimate of C$9.83 billion. Great-West Lifeco had a return on equity of 13.21% and a net margin of 11.32%.

Several other equities research analysts have also issued reports on the stock. TD Securities lifted their price target on shares of Great-West Lifeco from C$43.00 to C$44.00 and gave the company a "hold" rating in a research note on Wednesday, August 7th. Royal Bank of Canada upped their target price on Great-West Lifeco from C$45.00 to C$47.00 in a report on Thursday, August 8th. Jefferies Financial Group increased their price objective on Great-West Lifeco from C$42.00 to C$48.00 and gave the company a "hold" rating in a report on Wednesday, October 16th. Finally, Barclays set a C$43.00 price target on shares of Great-West Lifeco and gave the stock an "underweight" rating in a research report on Thursday, September 5th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, Great-West Lifeco currently has an average rating of "Hold" and an average price target of C$45.00.

Great-West Lifeco Stock Up 0.6 %

Shares of TSE GWO traded up C$0.30 during midday trading on Monday, reaching C$47.31. The company's stock had a trading volume of 703,625 shares, compared to its average volume of 2,663,771. The stock has a 50 day simple moving average of C$45.36 and a 200-day simple moving average of C$42.47. The company has a current ratio of 37.46, a quick ratio of 22.18 and a debt-to-equity ratio of 29.61. The stock has a market capitalization of C$44.10 billion, a price-to-earnings ratio of 11.89, a PEG ratio of 2.26 and a beta of 0.84. Great-West Lifeco has a fifty-two week low of C$37.47 and a fifty-two week high of C$47.76.

Great-West Lifeco Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 27th. Investors of record on Friday, September 27th were paid a $0.555 dividend. The ex-dividend date was Friday, August 30th. This represents a $2.22 dividend on an annualized basis and a yield of 4.69%. Great-West Lifeco's dividend payout ratio (DPR) is currently 55.78%.

Insider Buying and Selling at Great-West Lifeco

In other news, Director Richard Henry Linton sold 35,800 shares of the company's stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of C$46.27, for a total value of C$1,656,344.28. In other news, Director Charles Donald Harvey Henaire sold 25,400 shares of Great-West Lifeco stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of C$44.72, for a total value of C$1,135,888.00. Also, Director Richard Henry Linton sold 35,800 shares of the firm's stock in a transaction on Friday, October 4th. The stock was sold at an average price of C$46.27, for a total value of C$1,656,344.28. Insiders own 70.70% of the company's stock.

Great-West Lifeco Company Profile

Great-West Lifeco Inc engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, disability, critical illness, health and dental protection, and creditor insurance products; and retirement and wealth savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations.